Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.32 |
| ▸ | KAT5 | Q92993 | 1/20 | 0.32 |
| ▸ | KAT8 | Q9H7Z6 | 1/20 | 0.32 |
| ▸ | GRIN2B | Q13224 | 3/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL660526 | 0.78 | KAT6A (0.35) | ALDH1A1KMT2AMEN1MAPK1RAB9A | |
| SCHEMBL658639 | 0.76 | ALDH1A1 (0.39) | ALDH1A1KMT2AMAPK1RAB9AKAT6A | |
| SCHEMBL297855 | 0.75 | ALDH1A1 (0.42) | ALDH1A1KMT2AMEN1GRIN2BHTT | |
| SCHEMBL661083 | 0.75 | ALDH1A1 (0.39) | ALDH1A1KMT2AMEN1MAPK1LMNA | |
| SCHEMBL287773 | 0.75 | ALDH1A1 (0.39) | ALDH1A1KMT2AMEN1RAB9AHTT | |
| SCHEMBL659354 | 0.75 | ALDH1A1 (0.33) | ALDH1A1KMT2AMEN1MAPK1RAB9A | |
| SCHEMBL27545899 | 0.74 | ALDH1A1 (0.34) | ALDH1A1KMT2AMEN1MAPK1RAB9A | |
| SCHEMBL662691 | 0.74 | KMT2A (0.37) | ALDH1A1KMT2AMEN1MAPK1LMNA | |
| SCHEMBL287161 | 0.69 | CHRM5 (0.37) | ALDH1A1KMT2AMEN1GRIN2BHTT | |
| SCHEMBL660454 | 0.66 | KAT6A (0.51) | ALDH1A1KMT2AMEN1KAT6A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120046317-A1 | NOVEL HETEROCYCLIC COMPOUNDS | DUTT CHAITANYA (IN) | 2012-02-23 | — | — | US | claimed |
| US-20120046317-A1 | NOVEL HETEROCYCLIC COMPOUNDS | DUTT CHAITANYA (IN) | 2012-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120046317-A1 | NOVEL HETEROCYCLIC COMPOUNDS | AGER, REN, AGT | ALDH1A1 676/4885KMT2A 4512/4885MEN1 1455/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.